Fosamax - drug for treatment of Paget disease, osteoporosis at women in a postmenopause, osteoporosis at men, a hypercalcemia at malignant tumors. Active alendronate ingredient - non-hormonal specific inhibitor of an osteoclastic bone resorption, suppresses osteoclasts. Taking of Fosamax stimulates bone formation, recovers positive balance between a resorption and recovery of a bone, progressively increases the mineral density of bones, promotes formation of a normal bone tissue with normal histologic structure.
Your order will be packed safe and secure and dispatched within 24 hours. This is exactly how your parcel will look like (pictures of a real shipping item). It has a size and a look of a regular private letter (9.4x4.3x0.3 inches or 24x11x0.7cm) and it does not disclose its contents
Fosamax Product Description
Fosamax is a bone metabolism regulator, which helps people with osteoporosis to rebuild their bones and prevent bones from developing fractures. Osteoporosis is a disease that affects the bone tissue, and leads to bone fragility and frequent fractures.
The bone metabolism regulator Fosamax is indicated for treatment and prevention of:
- osteoporosis in postmenopausal women
- Paget 's disease of bone in men and women
- osteoporosis in men to reduce the incidence of fractures
- glucocorticoid-induced osteoporosis in men and women
For the treatment of metabolic bone diseases, men and women are advised to take Fosamax 10 mg daily or one 70 mg Fosamax pill once a week. The treatment duration with Fosamax is adjusted for each patient individually, and can range from 3 to 5 years.
Fosamax is recommended to be taken 10 mg daily or 70 mg once a week. If you forget to take your daily dose of Fosamax, wait for the time of the next dose if it comes soon, and skip the missed dose of the bone metabolism regulator. Doubling of Fosamax dose may cause side effects. If you’ve missed 1 weekly dose of Fosamax, you can take it the next morning and then return to compliance with the usual dosing regime of Fosamax.
Osteoporosis is most frequently met in women, especially during post menopause. The development of this disease is associated with the termination of the ovaries function and the production of the hormone estrogen. The earlier the menopause begins in a woman, the greater is the risk of osteoporosis. It should be noted that men can also have osteoporosis due to low testosterone levels (male sex hormone). However, men suffer from this disease times less than women.
Fosamax should be stored at temperature below 15°C. It is also desirable to protect the tablets from moisture and high temperatures.
Fosamax Safety Information
Fosamax may sometimes cause upper gastrointestinal adverse reactions. The patient should stop taking the bone metabolism regulator, if the symptoms are worsening. Treatment with Fosamax tablets may suddenly promote osteonecrosis of the jaw. Risk factors for this bone disease are invasive dentistry, comorbid disorders (periodontosis, clotting disorder, anemia).
The material about the musculoskeletal system disorders, provided in the review of the drug Fosamax, is published for informational purposes and is not intended as a substitute for seeking medical treatment or appropriate care of a qualified health care professional. The online pharmacy disclaims all liability for all claims and damages, occurred as a result of misuse of the review on Fosamax in the treatment of osteoporosis.Fosamax Safety Information.
Fosamax Side Effects
Clinical studies have shown that unwanted effects of Fosamax are mild in nature and are easily tolerated by both women and men. The dosage of the drug does not significantly affect the onset of unwanted effects in the treatment with Fosamax. The most common unwanted effects in the treatment with Fosamax are acid regurgitation, diarrhea, nausea, abdominal pain, dyspepsia, constipation, and musculoskeletal pain. Less likely, Fosamax may contribute to such unwanted effects, like dysphagia, dizziness, asthenia, flatulence, headache, peripheral oedema, alopecia, pruritus, and oesophageal ulcer.